Keshavarz-Rahaghi, Faeze
Pleasance, Erin
Jones, Steven J. M.
Funding for this research was provided by:
Canadian Institutes of Health Research
University of British Columbia
BC Cancer Foundation
Article History
Received: 21 February 2025
Accepted: 14 July 2025
First Online: 7 August 2025
Declarations
:
: TCGA data is available publicly. The POG program, registered under clinical trial number NCT02155621, was approved by the University of British Columbia – BC Cancer Research Ethics Board (H12-00137, H14-00681), and approved by the institutional review board.
: Not applicable.
: The authors declare no competing interests.